Commercial Products and Services
Compliance and Voluntary Disclosure
Foreign Sales/International Government Contracts
Government Finance & Privatization
Military Bases and Communities
Defensive Measures and Emergency Preparedness
Public Policy and Legislative Action
Public Health and Pharmaceutical Compliance
Radio Frequency Identification (RFID)
State and Local Government Contracts
Teaming Agreements and Subcontracts
Intellectual Property and Technology
PUBLIC HEALTH PREPAREDNESS: DESCRIPTION
McKenna Long & Aldridge LLP’s Public Health Preparedness practice is a multi-faceted resource for businesses interested in the emerging biodefense, pandemic influenza preparedness, detection and diagnostic industries. The firm helps clients develop and secure funding for new solutions to combat bioterrorism, including Chemical, Biological, Radiological, Nuclear and Explosive (CBRNE) terrorism and infectious diseases so they can create profitable partnerships between the pharmaceutical, vaccine, biotechnology, diagnostic and defense technology industries, the financial community and the government.
The Public Health Preparedness team integrates a full range of legal, political, governmental, scientific and business planning capabilities. Our clients enjoy the many benefits of the firm’s daily contact with political leaders, agency managers and company leaders who are spearheading the United States’ efforts to implement public health and preparedness programs.
We provide strategic government affairs and business solutions, counsel and due diligence reviews to investors and entities considering participation in the growing public health sector. We raise the profile of our clients’ science above their competitors to help secure government contracts and grants for offerings such as medical countermeasures, detection, protection and decontamination. The Public Health Preparedness team employs a range of business planning and government relations tools to successfully create domestic and international markets for countermeasures of interest to public health purchasers all over the globe.
The team also works to create profitable partnerships between the pharmaceutical, vaccine, biotechnology, diagnostic, detection and other defense technology industries as well as the Department of Health and Human Services (including the Centers for Disease Control and National Institutes of Health), Department of Homeland Security, Department of Defense, the European Union and various defense and health ministries throughout Europe.